1. Home
  2. SOUN vs STVN Comparison

SOUN vs STVN Comparison

Compare SOUN & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SoundHound AI Inc

SOUN

SoundHound AI Inc

HOLD

Current Price

$7.11

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$17.87

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOUN
STVN
Founded
2005
1949
Country
United States
Italy
Employees
954
N/A
Industry
EDP Services
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.7B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SOUN
STVN
Price
$7.11
$17.87
Analyst Decision
Buy
Buy
Analyst Count
7
3
Target Price
$15.00
$25.67
AVG Volume (30 Days)
22.6M
278.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
0.39%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$40.76
$9.67
Revenue Next Year
$20.02
$9.99
P/E Ratio
N/A
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$5.83
$12.89
52 Week High
$22.17
$28.00

Technical Indicators

Market Signals
Indicator
SOUN
STVN
Relative Strength Index (RSI) 36.85 55.46
Support Level $6.02 $17.23
Resistance Level $9.19 $19.05
Average True Range (ATR) 0.52 0.74
MACD -0.20 -0.13
Stochastic Oscillator 12.50 26.51

Price Performance

Historical Comparison
SOUN
STVN

About SOUN SoundHound AI Inc

SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: